BREAKING NEWS

BeyondSpring announces submission of New Drug Application (NDA) to U.S. FDA and China NMPA for Plinabulin and G-CSF combination for the prevention of chemotherapy-induced neutropenia (CIN).
Read more

01.07.2016

AACR Annual Meeting TME (2016)

Plinabulin: Evidence for an Immune-Mediated Mechanism of Action